"Designing Growth Strategies is in our DNA"
Pemphigus Vulgaris (PV) is a potentially fatal autoimmune disease. It results in the development of painful blisters on the mucous membrane of the skin, mouth, throat, nose, or genitals. Pemphigus Vulgaris (PV) is rare in nature. According to the National Organisation of Rare Disorders, Pemphigus Vulgaris (PV) is estimated to affect 0.7-5 people per 1,000,000 population per year across the globe.
Pemphigus Vulgaris (PV) is caused when the immune system of the body starts attacking the proteins that are present on the skin. The rising prevalence of the disease and active government support has resulted in many clinical studies and increased research investment by pharmaceutical companies. For example, Cabaletta Bio is conducting clinical trails on DSG3-CAART, a type of cell therapy for mucosal Pemphigus Vulgaris (PV).
To gain extensive insights into the market, Request for Customization
Global Pemphigus Vulgaris (PV) treatment market growth is being driven by the rising prevalence of the Pemphigus Vulgaris (PV), increase in the research investment, and active government support. Also, increasing awareness regarding the disease, and presence of potential pipeline candidates are anticipated to further boost the global Pemphigus Vulgaris (PV) treatment market during the forecast period.
However, limited treatment options and side effects associated with the currently used non-biological drugs are the primary reasons that may hinder the growth in the global Pemphigus Vulgaris (PV) treatment market.
Some of the major companies that are present in the global Pemphigus Vulgaris (PV) Treatment market report are F. Hoffmann-La Roche Ltd, Novartis AG, GlaxoSmithKline plc, Genentech, Inc., Vifor Pharma Management Ltd., Alexion, and others.
By Treatment Type
· Biological Therapies
· Intravenous Immunoglobulin (IVIG) Therapy
By Route of Administration
By Distribution Channel
· Hospital Pharmacy
· Retail Pharmacy
· Online Pharmacy
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
As per the current Pemphigus Vulgaris (PV) treatment market trends biological therapy segment, among the treatment type is anticipated to have a considerable growth owing to increasing demand for biological therapy for the treatment of diseases and reduced side effects.
The global Pemphigus Vulgaris (PV) treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global Pemphigus Vulgaris (PV) treatment market over the forecast period owing to the rising prevalence of the Pemphigus Vulgaris (PV), increased R&D spending, and presence of potential pipeline candidates. The Pemphigus Vulgaris (PV) treatment market in Europe is estimated to expand due to the active government support. In March 2019, Roche, one of the prominent players in the pharmaceutical industry received European Commission approval for MabThera for treating adults with Pemphigus Vulgaris (PV), which is expected to increase the market size of Europe. Improving health reforms, increasing awareness and demand for biological products is anticipated to favor the market expansion in Aisa Pacific, Latin America, and the Middle East and Africa.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry